How can companies keep pace with the demand in the combination products market while meeting or exceeding regulatory expectations of applying human factors engineering? This article provides an overview.
Specific dosing guidelines and acceptable dosage forms for pediatric patients need to be developed to optimize therapeutic efficacy and limit and prevent serious adverse side effects.
In this survey, 200+ people involved in the oral dose market shared their views on barriers to the development of oral formulations and technological responses to them.
White Paper | By Anthony Qu, Adare Pharma Solutions
A new R&D project shows that the solubility and dissolution characteristics of Itraconazole can be improved by helping to maintain an amorphous state after spray drying.
Case Study | By Dr. Laura Berardi, Stevanato Group
Learn how a partner who is committed to ensuring the safety of medical devices by mitigating the risk of chemical interaction with drugs is crucial for navigating the regulatory pathway to approval.
Discover how regulatory bodies are adopting a risk-based approach to address the unique challenges of genetic nanomedicines, and how stakeholder engagement is essential.
Review the case study and learn how KinetiSol Solid Dispersion lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
.png){kind=logo}
